Skip to main content
Sulggi Lee, MD, Infectious Disease, San Francisco, CA

Sulggi Angela Lee MD


Assistant Professor, Division of HIV, Infectious Diseases, & Global Medicine, UCSF School of Medicine

Join to View Full Profile
  • 995 Potrero Ave Bldg 80San Francisco, CA 94110

  • Phone+1 415-735-5127

  • Fax+1 415-476-6953

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Welcome to the Sulggi Lee Lab

    We perform translational HIV pathogenesis and cure studies, focused on identifying host genetic and immunologic predictors of HIV disease. Our goal is to integr

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Infectious Disease, 2010 - 2012
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2007 - 2010
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 2007

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Gut and Blood Differ in Constitutive Blocks to HIV Transcription, Suggesting Tissue-Specific Differences in the Mechanisms That Govern HIV Latency  
    Steven A Yukl, Ma Somsouk, Steven G Deeks, Sulggi Lee, Hiroyu Hatano, Peter W Hunt, Joseph K Wong, PLoS One
  • Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV‐1 Transcription in a Phase 2b Trial  
    Sulggi A Lee, Steven G Deeks, Clinical Pharmacology & Therapeutics

Press Mentions

  • Long-Haulers Are Pushing the Limits of COVID-19 Vaccines
    Long-Haulers Are Pushing the Limits of COVID-19 VaccinesMarch 25th, 2021
  • We Thought It Was Just a Respiratory Virus
    We Thought It Was Just a Respiratory VirusJuly 25th, 2020
  • This Gene Mutation May Hold the Clue to Why Some People Don't Get Covid-19
    This Gene Mutation May Hold the Clue to Why Some People Don't Get Covid-19July 26th, 2023

Grant Support

  • STudy of Acute HIV for investiGating Eradication Strategies (STAGES): The role of IL-10 and IFN signalingUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
  • Methamphetamine Activation of Inflammasome and Altered immunity in HIV (MAIA) StudyEMORY UNIVERSITY2024–2029
  • Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV diseaseUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2018–2026
  • STudy of Acute HIV for investiGating Eradication Strategies (STAGES)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2025
  • Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV diseaseUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2019–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: